Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells.
about
The role of gamma delta T cells in haematopoietic stem cell transplantationMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentOvercoming tumor immune evasion with an unique arbovirusKey Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer.γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytesA new effect of IL-4 on human γδ T cells: promoting regulatory Vδ1 T cells via IL-10 production and inhibiting function of Vδ2 T cellsNatural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells.An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivoComprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer.TCRγ4δ1-engineered αβT cells exhibit effective antitumor activityClonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance.Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γHuman γδT-cell subsets and their involvement in tumor immunity.Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation.Understanding the complexity of γδ T-cell subsets in mouse and human.The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy.At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Emerging Co-signaling Networks in T Cell Immune Regulation.Hunting for clinical translation with innate-like immune cells and their receptors.Natural cytotoxicity receptors and their ligands.Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activationγδ T cells in cancer.γδT Cells and Related Diseases.E. coli promotes human Vγ9Vδ2 T cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner.NKp46+ CD3+ cells: a novel nonconventional T cell subset in cattle exhibiting both NK cell and T cell features.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Suppression of allo-human leucocyte antigen (HLA) antibodies secreted by B memory cells in vitro: intravenous immunoglobulin (IVIg) versus a monoclonal anti-HLA-E IgG that mimics HLA-I reactivities of IVIg.Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI.Inhibition of R5-tropic HIV type-1 replication in CD4⁺ natural killer T cells by γδ T lymphocytes.Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.Morinda citrifolia edible leaf extract enhanced immune response against lung cancer.Apoptosis Induced via Gamma Delta T Cell Antigen Receptor "Blocking" Antibodies: A Cautionary TaleClinical significance of novel costimulatory molecule B7-H6 in human breast cancer.Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors.
P2860
Q27030355-01EA5CC5-A022-4F23-8019-8C57EDA9499DQ28073613-564AF59F-9FD3-4834-A032-F3A6FF3E5F98Q28081774-35633B4B-4A7D-412D-86A0-C274F6F0735EQ33855566-90CFF813-EFDE-4A1E-980F-3A5A24E95567Q35506504-6CF647FF-7067-4332-8A84-4D2FEBD45C0CQ35634919-713913CD-71C1-4502-84A5-5EE9640E0447Q36674426-6C7448FB-CD56-4212-9B90-CB8C0AEDAEEDQ36701917-1B9F50D1-8141-4251-9BCB-95B533EDD496Q36787587-4FADBA65-6D2D-4927-82F3-ABDF279D8347Q37370451-23CDDD29-7F0E-42A9-A57D-8FDED628E482Q37370559-E2909058-44F8-4EF3-9406-F8143CB37058Q37681825-F809F806-9608-4969-8203-96476CEC697CQ37701554-CBAEF960-EC44-4C3D-A256-6DC90DF9FE40Q37714642-CC896444-9D34-4E51-B590-8999E121F5B4Q37723095-41F59262-BC77-4105-B593-F54D26B1A697Q37990046-8E2CB9D9-FE31-4A4F-9FD4-2CADA643F37DQ38039112-EB01BD1D-4987-43B2-90D4-EA391D9801FBQ38149725-CF4855D8-8AAD-4443-B396-E9BD071DE4BEQ38151057-C7845DFE-3B1D-45D5-A6E2-B7BD1EE5F76EQ38160477-0B3B67EA-98DA-48F1-A09E-786409E9CCEFQ38171917-BC267132-5037-43F1-97BA-5ABD1C90ECD5Q38173692-7C7BF404-FCBE-44C6-8E08-4F50C182651EQ38217512-0FD586D4-221B-4D43-B6F5-AEEF416E263BQ38283536-E3526D69-6283-42F4-9859-E059DD07A844Q38352469-79252710-633A-4665-8678-6BF9FF3024BBQ38602555-8AB7083F-C33A-4F7B-B6E1-26EFAB891E5EQ38718920-861903C0-1C92-4A76-83DA-0B0E3C17C6BEQ38742060-A70439C1-01EA-4426-9F68-A43EC4214EE4Q38808106-EB89748A-4039-4AA6-83B7-351DDAAFB4A0Q38848219-148BECB4-33BE-4384-9DE9-09D08D3750C4Q39017122-08BED752-E139-4DCE-9719-36F611422847Q39055067-8BC9CB61-7BB3-4532-935C-A8302EFA0501Q39253138-40DDBE6B-08FE-42C5-8184-B680F4753586Q39324337-332E61B4-05BB-4254-82F3-78E497CC29AEQ39396311-05A2BADC-6F16-4835-A898-450A06633F6BQ40274003-D442E315-80E8-4413-A959-1D072D0E5307Q40977881-CB5907AF-C79C-4980-8F0F-938AB96985EFQ40989863-DA514526-16E6-4730-BB04-751CF97321CDQ41144481-E8BD6AD1-05A8-47C0-B85F-12DF9E9210B2Q42086300-626078A9-D1CA-4182-B12E-8C3AA711CF55
P2860
Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Differentiation of human perip ...... on of lymphoid leukemia cells.
@en
Differentiation of human perip ...... on of lymphoid leukemia cells.
@nl
type
label
Differentiation of human perip ...... on of lymphoid leukemia cells.
@en
Differentiation of human perip ...... on of lymphoid leukemia cells.
@nl
prefLabel
Differentiation of human perip ...... on of lymphoid leukemia cells.
@en
Differentiation of human perip ...... on of lymphoid leukemia cells.
@nl
P2093
P50
P1433
P1476
Differentiation of human perip ...... ion of lymphoid leukemia cells
@en
P2093
Kelly Hudspeth
Manuela Fogli
Maria Gomes da Silva
P304
P356
10.1182/BLOOD-2011-02-339135
P407
P577
2011-06-01T00:00:00Z